Review | Recall |
---|
Antihistamines | 17/17 |
Clopidogrel | 5/5 |
Echocardiography | 51/51 |
Eculizumab | 13/13 |
Oxygen therapy | 2/3* |
Parkinson’s | 43/43 |
Phenytoin | 6/6 |
Prostate cancer | 29/29 |
Sirolimus | 9/9†|
Thyroid cancer | 35/35 |
- *One reviewer identified all three studies
- †Review included 11 studies, with 2 not retrieved from bibliographic database searches and assumed to be from hand searches and therefore not included in the analysis but would have been retrieved with PICo screening